# Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

> **NCT01924689** · PHASE1 · COMPLETED · sponsor: **BioMed Valley Discoveries, Inc** · enrollment: 24 (actual)

## Conditions studied

- Solid Tumor Malignancies

## Interventions

- **BIOLOGICAL:** Clostridium novyi-NT spores

## Key facts

- **NCT ID:** NCT01924689
- **Lead sponsor:** BioMed Valley Discoveries, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-10-31
- **Final completion:** 2017-10-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924689, "Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01924689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*